In Brief: Gull Laboratories
This article was originally published in The Gray Sheet
Executive Summary
Gull Laboratories: Immunodiagnostics firm's majority shareholder Fresenius AG engages investment banking firm Wasserstein Perella & Co. to evaluate "various alternative" strategies for the unit, Gull states in an Oct. 23 release. Bad Homburg, Germany-based Fresenius, which holds a 62% stake in Gull, "has been approached by a number of firms expressing a potential interest in partnering or otherwise acquiring Gull," the firm states...